Loblaw Companies (TSE:L – Free Report) had its target price lifted by Royal Bank of Canada from C$205.00 to C$217.00 in a research note issued to investors on Monday morning,BayStreet.CA reports. The brokerage currently has an outperform rating on the stock.
L has been the subject of several other research reports. National Bankshares increased their target price on shares of Loblaw Companies from C$188.00 to C$195.00 in a research note on Thursday, November 14th. Desjardins increased their price target on shares of Loblaw Companies from C$172.00 to C$190.00 in a research report on Thursday, November 14th. TD Securities dropped their price objective on Loblaw Companies from C$203.00 to C$202.00 and set a “buy” rating for the company in a research note on Thursday, November 14th. Finally, CIBC increased their price target on Loblaw Companies from C$189.00 to C$206.00 in a research report on Thursday, November 14th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, Loblaw Companies presently has a consensus rating of “Moderate Buy” and an average price target of C$193.00.
Check Out Our Latest Stock Analysis on Loblaw Companies
Loblaw Companies Stock Up 0.5 %
Loblaw Companies Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 30th. Stockholders of record on Sunday, December 15th will be issued a dividend of $0.513 per share. This represents a $2.05 annualized dividend and a dividend yield of 1.07%. The ex-dividend date of this dividend is Friday, December 13th. Loblaw Companies’s dividend payout ratio (DPR) is presently 31.06%.
About Loblaw Companies
Loblaw is one of Canada’s largest grocery, pharmacy, and general merchandise retailers, operating the most expansive store footprint in Ontario and maintaining sizable presences in provinces like Quebec and British Columbia. Key grocery banners include Loblaw, No Frills, and Maxi, while its pharmaceutical operations are the product of its 2014 acquisition of Shoppers Drug Mart.
Featured Stories
- Five stocks we like better than Loblaw Companies
- The Significance of Brokerage Rankings in Stock Selection
- How to Master Trading Discipline: Overcome Emotional Challenges
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Does China Investigation Change NVIDIA’s Outlook; Yes, No, Maybe?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Is Marvell Technology Chipping Away at NVIDIA’s Market Lead?
Receive News & Ratings for Loblaw Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loblaw Companies and related companies with MarketBeat.com's FREE daily email newsletter.